HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Find → Understand → Decide

Stranded asset discovery

Find leads where development or the surrounding company stopped. Discovery priority is separate from buyer qualification.

Bounded historical coverage · 0 HIGH / 111 MEDIUM / 956 LOW. No current availability or investment recommendation is implied. SEC retrieval is partial.

1067 exact-label leads · page 32

LOW · POSSIBLE / INVESTIGATE

Definity

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · UNKNOWN

degarelix

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · UNKNOWN confidence · New label

LOW · POSSIBLE / INVESTIGATE

Delafloxacin

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · Prior label overlap

LOW · POSSIBLE / INVESTIGATE

Delafloxacin Powder

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · Prior label overlap

LOW · POSSIBLE / INVESTIGATE

Dendritic Cell (DC1) Vaccine

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · Prior label overlap

LOW · POSSIBLE / INVESTIGATE

Dendritic Cell/Tumor Fusion Vaccine

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

Denosumab

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

Densiron [(F6H8)

Why stranded (event context): recruitment/execution failure

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · UNKNOWN

Depmedrol

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · UNKNOWN confidence · New label

LOW · POSSIBLE / INVESTIGATE

Determination of viral load in tissues by qRT-PCR

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

Deucravacitinib 6mg po qd

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

DEX group: Dexamethasone

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label